IMPURITIES AVAILABLE FOR 'Safinamide'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Safinamide. Safinamide is an oral, selective, and reversible monoamine oxidase-B (MAO-B) inhibitor used as an adjunct therapy in Parkinson’s disease. It enhances dopaminergic activity by inhibiting MAO-B–mediated dopamine breakdown in the brain. In addition to MAO-B inhibition, safinamide modulates abnormal glutamate release through sodium channel blockade and calcium channel modulation. This dual mechanism helps improve motor symptoms and reduce “off” time in patients already taking levodopa. Safinamide has a favorable safety profile with once-daily dosing. Common adverse effects include dyskinesia, insomnia, and nausea. It does not significantly inhibit MAO-A at therapeutic doses, reducing dietary tyramine concerns. The drug is extensively metabolized and excreted mainly via urine. Safinamide offers a unique multimodal approach among Parkinson’s disease adjunctive treatments. Buy high quality Safinamide from Omsynth Lifesciences.